Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""THYROID cancer"" wg kryterium: Temat


Starter badań:

Tytuł:
Single-cell RNA-seq reveals MIF-(CD74 + CXCR4) dependent inhibition of macrophages in metastatic papillary thyroid carcinoma.
Autorzy:
Chen W; Department of Head & Neck Surgery, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, China. Electronic address: chenwei_.
Yu X; Department of Medical Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, China. Electronic address: .
Li H; Department of Gynaecology, The Affiliated Obstetrics and Gynaecology Hospital of Nanjing Medical University & Nanjing Maternity and Child Health Care Hospital, Nanjing 210004, China. Electronic address: .
Yuan S; Department of Gynaecology, The Affiliated Obstetrics and Gynaecology Hospital of Nanjing Medical University & Nanjing Maternity and Child Health Care Hospital, Nanjing 210004, China. Electronic address: .
Fu Y; Department of Medical Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, China. Electronic address: .
Hu H; Department of Gynaecology, The Affiliated Obstetrics and Gynaecology Hospital of Nanjing Medical University & Nanjing Maternity and Child Health Care Hospital, Nanjing 210004, China. Electronic address: .
Liu F; Department of Head & Neck Surgery, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, China. Electronic address: .
Zhang Y; Department of Head & Neck Surgery, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, China. Electronic address: zhangyuan_.
Zhong S; Center of Clinical Laboratory Science, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, China. Electronic address: .
Pokaż więcej
Źródło:
Oral oncology [Oral Oncol] 2024 Jan; Vol. 148, pp. 106654. Date of Electronic Publication: 2023 Dec 06.
Typ publikacji:
Journal Article
MeSH Terms:
Macrophage Migration-Inhibitory Factors*/genetics
Macrophage Migration-Inhibitory Factors*/metabolism
Macrophages*/metabolism
Thyroid Cancer, Papillary*/immunology
Thyroid Cancer, Papillary*/pathology
Thyroid Neoplasms*/immunology
Thyroid Neoplasms*/pathology
Female ; Humans ; Intramolecular Oxidoreductases/metabolism ; Lymphatic Metastasis/genetics ; Receptors, CXCR4/genetics ; Receptors, CXCR4/metabolism ; Single-Cell Gene Expression Analysis
Czasopismo naukowe
Tytuł:
Delving into the Role of lncRNAs in Papillary Thyroid Cancer: Upregulation of LINC00887 Promotes Cell Proliferation, Growth and Invasion.
Autorzy:
Tous C; Department of Maternofetal Medicine, Genetics and Reproduction, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, 41013 Seville, Spain.; Center for Biomedical Network Research on Rare Diseases (CIBERER), 41013 Seville, Spain.
Muñoz-Redondo C; Department of Maternofetal Medicine, Genetics and Reproduction, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, 41013 Seville, Spain.; Center for Biomedical Network Research on Rare Diseases (CIBERER), 41013 Seville, Spain.
Gavilán A; Department of Maternofetal Medicine, Genetics and Reproduction, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, 41013 Seville, Spain.
Bravo-Gil N; Department of Maternofetal Medicine, Genetics and Reproduction, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, 41013 Seville, Spain.; Center for Biomedical Network Research on Rare Diseases (CIBERER), 41013 Seville, Spain.
Baco-Antón F; Department of Maternofetal Medicine, Genetics and Reproduction, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, 41013 Seville, Spain.
Navarro-González E; Center for Biomedical Network Research on Rare Diseases (CIBERER), 41013 Seville, Spain.; Department of Endocrinology and Nutrition, University Hospital Virgen del Rocío, 41013 Seville, Spain.
Antiñolo G; Department of Maternofetal Medicine, Genetics and Reproduction, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, 41013 Seville, Spain.; Center for Biomedical Network Research on Rare Diseases (CIBERER), 41013 Seville, Spain.
Borrego S; Department of Maternofetal Medicine, Genetics and Reproduction, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, 41013 Seville, Spain.; Center for Biomedical Network Research on Rare Diseases (CIBERER), 41013 Seville, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 27; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 27.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Papillary*/genetics
Carcinoma, Papillary*/metabolism
RNA, Long Noncoding*/genetics
Thyroid Cancer, Papillary*/genetics
Thyroid Cancer, Papillary*/pathology
Thyroid Neoplasms*/genetics
Thyroid Neoplasms*/pathology
Humans ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Up-Regulation/genetics
Czasopismo naukowe
Tytuł:
Investigating USP42 Mutation as Underlying Cause of Familial Non-Medullary Thyroid Carcinoma.
Autorzy:
Teixeira E; Cancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.; Cancer Signalling and Metabolism Group do Instituto de Patologia e Imunologia Molecular da Universidade do Porto-Ipatimup, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal.; Departamento de Biomedicina da Faculdade de Medicina da Universidade do Porto-FMUP, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.
Fernandes C; Cancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.; Cancer Signalling and Metabolism Group do Instituto de Patologia e Imunologia Molecular da Universidade do Porto-Ipatimup, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal.; Departamento de Bioquímica da Faculdade de Ciências da Universidade do Porto-FCUP, Rua do Campo Alegre 1021 1055, 4169-007 Porto, Portugal.; Departamento de Patologia e Imunologia Molecular do Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto-ICBAS, R. Jorge de Viterbo Ferreira 228, 4050-313 Porto, Portugal.
Bungărdean M; Department of Pathology, Iuliu Haţieganu University of Medicine and Pharmacy, Municipal Clinical Hospital, Cluj-Napoca 400139, Romania.
Paula ADC; Cancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.; Cancer Signalling and Metabolism Group do Instituto de Patologia e Imunologia Molecular da Universidade do Porto-Ipatimup, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal.
Lima RT; Cancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.; Cancer Signalling and Metabolism Group do Instituto de Patologia e Imunologia Molecular da Universidade do Porto-Ipatimup, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal.; Departamento de Patologia da Faculdade de Medicina da Universidade do Porto-FMUP, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.
Batista R; Cancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.; Cancer Signalling and Metabolism Group do Instituto de Patologia e Imunologia Molecular da Universidade do Porto-Ipatimup, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal.
Vinagre J; Cancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.; Cancer Signalling and Metabolism Group do Instituto de Patologia e Imunologia Molecular da Universidade do Porto-Ipatimup, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal.; Departamento de Patologia da Faculdade de Medicina da Universidade do Porto-FMUP, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.
Sobrinho-Simões M; Cancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.; Cancer Signalling and Metabolism Group do Instituto de Patologia e Imunologia Molecular da Universidade do Porto-Ipatimup, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal.; Departamento de Patologia da Faculdade de Medicina da Universidade do Porto-FMUP, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.
Máximo V; Cancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.; Cancer Signalling and Metabolism Group do Instituto de Patologia e Imunologia Molecular da Universidade do Porto-Ipatimup, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal.; Departamento de Patologia da Faculdade de Medicina da Universidade do Porto-FMUP, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.
Soares P; Cancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.; Cancer Signalling and Metabolism Group do Instituto de Patologia e Imunologia Molecular da Universidade do Porto-Ipatimup, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal.; Departamento de Patologia da Faculdade de Medicina da Universidade do Porto-FMUP, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 26; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 26.
Typ publikacji:
Journal Article
MeSH Terms:
Thyroid Cancer, Papillary*/genetics
Thyroid Neoplasms*/genetics
Thyroid Neoplasms*/pathology
Ubiquitin-Specific Proteases*/genetics
Humans ; Caspase 3/genetics ; Genetic Predisposition to Disease ; Mutation ; Thiolester Hydrolases/genetics ; Tumor Suppressor Protein p53/genetics
Czasopismo naukowe
Tytuł:
Endoscopic thyroidectomy via areola approach for stage T1 papillary thyroid carcinoma: feasibility, safety, and oncologic outcomes.
Autorzy:
Huo J; Department of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.; Department of Breast and Thyroid Surgery, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou, China.
Xu Y; Department of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Yu J; Department of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Guo Y; Department of Breast and Thyroid Surgery, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou, China.
Hu X; Department of Breast and Thyroid Surgery, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou, China.
Ou D; Department of Oncology, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou, China.
Qu R; Department of Breast and Thyroid Surgery, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou, China.
Zhao L; Department of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Nov 23; Vol. 14, pp. 1212490. Date of Electronic Publication: 2023 Nov 23 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Thyroid Cancer, Papillary*/pathology
Thyroid Cancer, Papillary*/surgery
Thyroid Neoplasms*/surgery
Thyroid Neoplasms*/pathology
Thyroidectomy*/adverse effects
Thyroidectomy*/methods
Humans ; Feasibility Studies ; Nipples/pathology ; Quality of Life ; Endoscopy ; Treatment Outcome
Czasopismo naukowe
Tytuł:
A tumor-suppressing role of TSPYL2 in thyroid cancer: Through interacting with SIRT1 and repressing SIRT1/AKT pathway.
Autorzy:
Zhang X; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, 110004, PR China.
Wu X; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, 110004, PR China.
Yao W; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, 110004, PR China.
Wang YH; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, 110004, PR China. Electronic address: .
Pokaż więcej
Źródło:
Experimental cell research [Exp Cell Res] 2023 Nov 01; Vol. 432 (1), pp. 113777. Date of Electronic Publication: 2023 Sep 09.
Typ publikacji:
Journal Article
MeSH Terms:
Thyroid Cancer, Papillary*/pathology
Thyroid Neoplasms*/pathology
Humans ; Male ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Proto-Oncogene Proteins c-akt/metabolism ; Sirtuin 1/genetics ; Sirtuin 1/metabolism
Czasopismo naukowe
Tytuł:
Prevalence of Occult Central Lymph Node Metastasis by Tumor Size in Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
Autorzy:
Tang L; Department of Otolaryngology-Head and Neck Surgery, Loma Linda University Medical Center, Loma Linda, CA 92354, USA.
Qu RW; Department of Otolaryngology-Head and Neck Surgery, Loma Linda University Medical Center, Loma Linda, CA 92354, USA.
Park J; Department of Otolaryngology-Head and Neck Surgery, Loma Linda University Medical Center, Loma Linda, CA 92354, USA.
Simental AA; Department of Otolaryngology-Head and Neck Surgery, Loma Linda University Medical Center, Loma Linda, CA 92354, USA.
Inman JC; Department of Otolaryngology-Head and Neck Surgery, Loma Linda University Medical Center, Loma Linda, CA 92354, USA.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Aug 02; Vol. 30 (8), pp. 7335-7350. Date of Electronic Publication: 2023 Aug 02.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Thyroid Cancer, Papillary*/pathology
Lymph Nodes*
Head and Neck Neoplasms*/secondary
Neoplasm Metastasis ; Humans
Czasopismo naukowe
Tytuł:
Minimal change disease with papillary thyroid carcinoma: a report of two adult cases.
Autorzy:
Yin J; Department of Nephrology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China.
Li Z; Department of Nephrology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China.
Hao Z; Department of General Surgery, the First People's Hospital of Jinzhong, Jinzhong, 030699, China.
Yu Z; Department of Pathology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, China.
Yu W; Department of Nephrology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China.
Yang G; Taiyuan Kingmed Clinical Laboratory Co., Ltd, Taiyuan, China.
Ren X; Department of Nephrology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China. .
Pokaż więcej
Źródło:
BMC nephrology [BMC Nephrol] 2023 Jul 05; Vol. 24 (1), pp. 202. Date of Electronic Publication: 2023 Jul 05.
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Nephrosis, Lipoid*/complications
Nephrosis, Lipoid*/diagnosis
Nephrosis, Lipoid*/therapy
Thyroid Cancer, Papillary*/complications
Thyroid Neoplasms*/complications
Adult ; Female ; Humans ; Male ; Middle Aged ; Prednisone/therapeutic use ; Thyroidectomy ; Nephrotic Syndrome
Czasopismo naukowe
Tytuł:
Successful management of a difficult airway in a case of advanced thyroid cancer.
Autorzy:
Unar AA; Department of Surgery, Aga Khan University Hospital, Karachi, Pakistan.
Shamim F; Department of Anaesthesiology, Aga Khan University Hospital, Karachi, Pakistan.
Deewani MH; Department of Surgery, Aga Khan University Hospital, Karachi, Pakistan.
Wasif M; Department of Surgery, Aga Khan University Hospital, Karachi, Pakistan.
Ikram M; Department of Surgery, Aga Khan University Hospital, Karachi, Pakistan.
Pokaż więcej
Źródło:
JPMA. The Journal of the Pakistan Medical Association [J Pak Med Assoc] 2023 May; Vol. 73 (5), pp. 1095-1099.
Typ publikacji:
Case Reports
MeSH Terms:
Thyroid Neoplasms*/pathology
Thyroid Neoplasms*/surgery
Thyroidectomy*/methods
Thyroid Cancer, Papillary*/pathology
Thyroid Cancer, Papillary*/surgery
Humans ; Neoplasm Invasiveness/pathology ; Retrospective Studies ; Trachea/surgery ; Neoplasm Staging ; Airway Management ; Treatment Outcome ; Female ; Middle Aged
Raport
Tytuł:
Modified dynamic risk stratification system further predicts individual outcome in patients with intermediate-risk papillary thyroid cancer.
Autorzy:
Cuéllar DI; Clinical and Epidemiological Cancer Research Unit, Instituto Nacional de Cancerología, Bogotá Calle 1 9-85 Bogotá, Colombia. Electronic address: dcuellar@cancer.gov.co.
De Los Reyes A; Emeritus Professor, Instituto Nacional de Cancerología, Bogotá, Colombia.
Llamas-Olier A; Emeritus Professor, Instituto Nacional de Cancerología, Bogotá, Colombia.
Pokaż więcej
Źródło:
Annales d'endocrinologie [Ann Endocrinol (Paris)] 2023 Apr; Vol. 84 (2), pp. 242-248. Date of Electronic Publication: 2022 Apr 25.
Typ publikacji:
Journal Article
MeSH Terms:
Thyroid Cancer, Papillary*/therapy
Thyroid Neoplasms*/therapy
Thyroidectomy*
Iodine Radioisotopes*/therapeutic use
Retrospective Studies ; Risk Adjustment ; Neoplasm Recurrence, Local ; Disease Management ; Treatment Outcome ; Colombia ; Humans ; Male ; Female ; Middle Aged ; Aged ; Aged, 80 and over
Czasopismo naukowe
Tytuł:
Age-Dependent Clinicopathological Characteristics of Patients with T1b Papillary Thyroid Carcinoma: Implications for the Possibility of Active Surveillance.
Autorzy:
Won HR; Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.; Department of Otorhinolaryngology-Head and Neck Surgery, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.
Jeon E; Department of Internal Medicine, School of Medicine, Daegu Catholic University, Daegu, Republic of Korea.
Heo DB; Department of Otorhinolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Republic of Korea.
Chang JW; Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.; Department of Otorhinolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Republic of Korea.
Shong M; Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.; Division of Endocrinology and Metabolism, Departments of Internal Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.
Kim JR; Department of Surgery, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
Ko H; Department of Surgery, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
Kang YE; Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
Yi HS; Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
Lee JH; Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
Joung KH; Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.; Division of Endocrinology and Metabolism, Departments of Internal Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.
Kim JM; Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.; Division of Endocrinology and Metabolism, Departments of Internal Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.
Lee Y; Departments of Surgery, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.
Kim SW; Department of Internal Medicine, School of Medicine, Daegu Catholic University, Daegu, Republic of Korea.
Jeong YJ; Department of Surgery, School of Medicine, Daegu Catholic University, Daegu, Republic of Korea.
Ji YB; Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Hanyang University, Seoul, Republic of Korea.
Tae K; Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Hanyang University, Seoul, Republic of Korea. .
Koo BS; Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Chungnam National University, Daejeon, Republic of Korea. .; Department of Otorhinolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Republic of Korea. .
Pokaż więcej
Corporate Authors:
MASTER Study Group
Źródło:
Annals of surgical oncology [Ann Surg Oncol] 2023 Apr; Vol. 30 (4), pp. 2246-2253. Date of Electronic Publication: 2022 Dec 29.
Typ publikacji:
Journal Article
MeSH Terms:
Thyroid Cancer, Papillary*/surgery
Thyroid Cancer, Papillary*/pathology
Thyroid Neoplasms*/surgery
Thyroid Neoplasms*/pathology
Watchful Waiting*
Aged ; Humans ; Male ; Middle Aged ; Cohort Studies ; Lymphatic Metastasis ; Retrospective Studies ; Thyroidectomy ; Female
Czasopismo naukowe
Tytuł:
Combined clinical variable and radiomics of post-treatment total body scan for prediction of successful I-131 ablation in low-risk papillary thyroid carcinoma patients.
Autorzy:
Chantadisai M; Division of Nuclear Medicine, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. aueng_.; Division of Nuclear Medicine, Department of Radiology, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand. aueng_.
Wongwijitsook J; Division of Nuclear Medicine, Department of Radiology, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.; Division of Nuclear Medicine, Department of Radiology, Surin Hospital, Surin, Thailand.
Ritlumlert N; Chulalongkorn University Biomedical Imaging Group, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Biomedical Engineering Program, Faculty of Engineering, Chulalongkorn University, Bangkok, Thailand.; School of Radiological Technology, Faculty of Health Science Technology, Chulabhorn Royal Academy, Bangkok, Thailand.
Rakvongthai Y; Division of Nuclear Medicine, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Chulalongkorn University Biomedical Imaging Group, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 29; Vol. 14 (1), pp. 5001. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:
Journal Article
MeSH Terms:
Thyroid Neoplasms*/diagnostic imaging
Thyroid Neoplasms*/radiotherapy
Thyroid Neoplasms*/surgery
Humans ; Thyroid Cancer, Papillary/diagnostic imaging ; Thyroid Cancer, Papillary/radiotherapy ; Thyroid Cancer, Papillary/surgery ; Iodine Radioisotopes/therapeutic use ; Retrospective Studies ; Radiomics
Czasopismo naukowe
Tytuł:
Active Surveillance for Low-Risk Papillary Thyroid Carcinoma as an Acceptable Management Option with Additional Benefits: A Comprehensive Systematic Review.
Autorzy:
Yoon JH; Department of Internal Medicine Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea.
Choi W; Department of Internal Medicine Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea.
Park JY; Department of Internal Medicine Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea.
Hong AR; Department of Internal Medicine Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea.
Kim HK; Department of Internal Medicine Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea.
Kang HC; Department of Internal Medicine Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea.
Pokaż więcej
Źródło:
Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2024 Feb; Vol. 39 (1), pp. 152-163. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Systematic Review; Journal Article
MeSH Terms:
Thyroid Neoplasms*/pathology
Humans ; Thyroid Cancer, Papillary/surgery ; Thyroid Cancer, Papillary/pathology ; Quality of Life ; Thyroidectomy ; Watchful Waiting ; Disease Progression
Czasopismo naukowe
Tytuł:
Impact of the number of intermediate risk factors on outcome of papillary thyroid cancer.
Autorzy:
Cerci MO; Endocrinology Division, Department of Internal Medicine, School of Medical Sciences, University of Campinas, São Paulo, Brazil.
de Assumpção LVM; Endocrinology Division, Department of Internal Medicine, School of Medical Sciences, University of Campinas, São Paulo, Brazil.
Zantut-Wittmann DE; Endocrinology Division, Department of Internal Medicine, School of Medical Sciences, University of Campinas, São Paulo, Brazil. .
Pokaż więcej
Źródło:
Endocrine [Endocrine] 2024 Feb; Vol. 83 (2), pp. 442-448. Date of Electronic Publication: 2023 Sep 12.
Typ publikacji:
Journal Article
MeSH Terms:
Thyroid Neoplasms*/pathology
Humans ; Thyroid Cancer, Papillary/pathology ; Thyroidectomy ; Neoplasm Recurrence, Local/pathology ; Risk Factors ; Retrospective Studies ; Prognosis
Czasopismo naukowe
Tytuł:
Construction of a nomogram for central lymph node metastasis in papillary thyroid cancer based on gender grouping.
Autorzy:
Qi GF; Department of Thyroid Surgery, The Third Affiliated Hospital of Soochow University, Changzhou First People's Hospital, Changzhou, Jiangsu, China.
Feng JW; Department of Thyroid Surgery, The Third Affiliated Hospital of Soochow University, Changzhou First People's Hospital, Changzhou, Jiangsu, China.
Wu WX; Department of Thyroid Surgery, The Third Affiliated Hospital of Soochow University, Changzhou First People's Hospital, Changzhou, Jiangsu, China.
Ye J; Department of Thyroid Surgery, The Third Affiliated Hospital of Soochow University, Changzhou First People's Hospital, Changzhou, Jiangsu, China.
Hu J; Department of Thyroid Surgery, The Third Affiliated Hospital of Soochow University, Changzhou First People's Hospital, Changzhou, Jiangsu, China.
Wang F; Department of Thyroid Surgery, The Third Affiliated Hospital of Soochow University, Changzhou First People's Hospital, Changzhou, Jiangsu, China.
Hong LZ; Department of Thyroid Surgery, The Third Affiliated Hospital of Soochow University, Changzhou First People's Hospital, Changzhou, Jiangsu, China.
Liu SY; Department of Thyroid Surgery, The Third Affiliated Hospital of Soochow University, Changzhou First People's Hospital, Changzhou, Jiangsu, China.
Jiang Y; Department of Thyroid Surgery, The Third Affiliated Hospital of Soochow University, Changzhou First People's Hospital, Changzhou, Jiangsu, China. .
Pokaż więcej
Źródło:
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2024 Feb; Vol. 281 (2), pp. 965-975. Date of Electronic Publication: 2023 Nov 17.
Typ publikacji:
Journal Article
MeSH Terms:
Thyroid Neoplasms*/surgery
Thyroid Neoplasms*/pathology
Carcinoma, Papillary*/pathology
Humans ; Male ; Female ; Thyroid Cancer, Papillary/surgery ; Thyroid Cancer, Papillary/pathology ; Nomograms ; Retrospective Studies ; Lymphatic Metastasis/pathology ; Lymph Nodes/surgery ; Lymph Nodes/pathology ; Risk Factors
Czasopismo naukowe
Tytuł:
Meta-analysis of the effect and clinical significance of Delphian lymph node metastasis in papillary thyroid cancer.
Autorzy:
Chen Y; Division of thyroid Surgery, China-Japan Union Hospital Of Jilin University, Jilin University, Changchun, China.
Wang Y; Division of thyroid Surgery, China-Japan Union Hospital Of Jilin University, Jilin University, Changchun, China.
Li C; Division of thyroid Surgery, China-Japan Union Hospital Of Jilin University, Jilin University, Changchun, China.
Zhang X; Division of thyroid Surgery, China-Japan Union Hospital Of Jilin University, Jilin University, Changchun, China.
Fu Y; Division of thyroid Surgery, China-Japan Union Hospital Of Jilin University, Jilin University, Changchun, China.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Jan 19; Vol. 14, pp. 1295548. Date of Electronic Publication: 2024 Jan 19 (Print Publication: 2023).
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Carcinoma, Papillary*/surgery
Thyroid Neoplasms*/pathology
Humans ; Thyroid Cancer, Papillary/surgery ; Thyroid Cancer, Papillary/secondary ; Lymphatic Metastasis ; Clinical Relevance
Czasopismo naukowe
Tytuł:
Effect of Hashimoto's thyroiditis on the dual-energy CT quantitative parameters and performance in diagnosing metastatic cervical lymph nodes in patients with papillary thyroid cancer.
Autorzy:
Geng D; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Nanjing, PR China.
Zhou Y; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Nanjing, PR China.
Shang T; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Nanjing, PR China.; Department of Radiology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine of Nanjing University of Chinese Medicine, Nanjing, China.
Su GY; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Nanjing, PR China.
Lin SS; Siemens Healthineers Ltd, Shanghai, China.
Si Y; Department of Thyroid Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wu FY; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Nanjing, PR China. wfy_.
Xu XQ; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Nanjing, PR China. xiaoquanxu_.
Pokaż więcej
Źródło:
Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2024 Jan 18; Vol. 24 (1), pp. 10. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Iodine*
Thyroid Neoplasms*/diagnostic imaging
Thyroid Neoplasms*/pathology
Thyroiditis*/complications
Thyroiditis*/pathology
Humans ; Thyroid Cancer, Papillary/complications ; Thyroid Cancer, Papillary/pathology ; Lymph Nodes/diagnostic imaging ; Lymph Nodes/pathology ; Tomography, X-Ray Computed/methods ; Retrospective Studies
Czasopismo naukowe
Tytuł:
First Evidence of Mineralocorticoid Receptor Gene and Protein Expression in Rat and Human Thyroid Tissues and Cell Cultures.
Autorzy:
Manso J; Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Via Ospedale Civile 105, 35128 Padua, Italy.
Pedron MC; Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Via Ospedale Civile 105, 35128 Padua, Italy.
Mondin A; Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Via Ospedale Civile 105, 35128 Padua, Italy.
Censi S; Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Via Ospedale Civile 105, 35128 Padua, Italy.
Pennelli G; Surgical Pathology Unit, Department of Medicine (DIMED), University of Padua, Via Ospedale Civile 105, 35128 Padua, Italy.
Galuppini F; Surgical Pathology Unit, Department of Medicine (DIMED), University of Padua, Via Ospedale Civile 105, 35128 Padua, Italy.
Barollo S; Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Via Ospedale Civile 105, 35128 Padua, Italy.
Bertazza L; Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Via Ospedale Civile 105, 35128 Padua, Italy.
Radu CM; General Internal Medicine and Thrombotic and Haemorrhagic Diseases Unit, Department of Medicine (DIMED), University of Padua, Via Ospedale Civile 105, 35128 Padua, Italy.
Ghini F; Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Via Ospedale Civile 105, 35128 Padua, Italy.
Simioni P; General Internal Medicine and Thrombotic and Haemorrhagic Diseases Unit, Department of Medicine (DIMED), University of Padua, Via Ospedale Civile 105, 35128 Padua, Italy.
Sabbadin C; Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Via Ospedale Civile 105, 35128 Padua, Italy.
Ceccato F; Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Via Ospedale Civile 105, 35128 Padua, Italy.
Armanini D; Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Via Ospedale Civile 105, 35128 Padua, Italy.
Mian C; Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Via Ospedale Civile 105, 35128 Padua, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 06; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 06.
Typ publikacji:
Journal Article
MeSH Terms:
Receptors, Mineralocorticoid*/genetics
Thyroid Neoplasms*
Animals ; Humans ; Rats ; Aldosterone/pharmacology ; Cell Culture Techniques ; Mineralocorticoids ; Thyroid Cancer, Papillary
Czasopismo naukowe
Tytuł:
Single-cell sequencing reveals SATB2/NOTCH1 signaling promotes the progression of malignancy of epithelial cells from papillary thyroid cancer.
Autorzy:
Zhang W; Department of Head and Neck Surgery, Cancer Hospital of China Medical University, Shenyang, China.
Wang J; Department of Head and Neck Surgery, Cancer Hospital of China Medical University, Shenyang, China.
Huang D; Department of Head and Neck Surgery, Cancer Hospital of China Medical University, Shenyang, China.
Liu Z; Department of Head and Neck Surgery, Cancer Hospital of China Medical University, Shenyang, China.
Lu T; Department of Head and Neck Surgery, Cancer Hospital of China Medical University, Shenyang, China.
Cui C; Department of Head and Neck Surgery, Cancer Hospital of China Medical University, Shenyang, China.
Li Z; Department of Head and Neck Surgery, Cancer Hospital of China Medical University, Shenyang, China.
Pokaż więcej
Źródło:
Molecular carcinogenesis [Mol Carcinog] 2024 Jan; Vol. 63 (1), pp. 22-33. Date of Electronic Publication: 2023 Oct 25.
Typ publikacji:
Journal Article
MeSH Terms:
Thyroid Neoplasms*/pathology
Matrix Attachment Region Binding Proteins*/genetics
Matrix Attachment Region Binding Proteins*/metabolism
Humans ; Thyroid Cancer, Papillary/genetics ; Thyroid Cancer, Papillary/pathology ; Cell Line, Tumor ; Signal Transduction/genetics ; Epithelial Cells/metabolism ; Transcription Factors/genetics ; Transcription Factors/metabolism ; Cell Proliferation/genetics ; Cell Movement/genetics ; Gene Expression Regulation, Neoplastic ; Receptor, Notch1/genetics ; Receptor, Notch1/metabolism
Czasopismo naukowe
Tytuł:
Spleen tyrosine kinase facilitates the progression of papillary thyroid cancer regulated by the hsa_circ_0006417/miR-377-3p axis.
Autorzy:
Tan G; Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.; Cancer Center, Southern Medical University, Guangzhou, China.; Department of Head and Neck Surgery, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
Zheng S; Department of Head and Neck Surgery, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
Zhou B; Department of Hepatobiliary Surgery, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Mo Z; Department of Hepatobiliary Surgery, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Zhang Q; Department of Pathology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
Zhang D; Department of Pathology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
Li A; Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.; Cancer Center, Southern Medical University, Guangzhou, China.
Liu X; Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.; Cancer Center, Southern Medical University, Guangzhou, China.
Pokaż więcej
Źródło:
Environmental toxicology [Environ Toxicol] 2024 Jan; Vol. 39 (1), pp. 421-434. Date of Electronic Publication: 2023 Oct 04.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*/genetics
MicroRNAs*/metabolism
Syk Kinase*/genetics
Thyroid Neoplasms*/metabolism
RNA, Circular*/genetics
Humans ; Cell Line, Tumor ; Cell Proliferation/genetics ; Thyroid Cancer, Papillary/genetics ; Thyroid Cancer, Papillary/metabolism ; Thyroid Cancer, Papillary/pathology ; TOR Serine-Threonine Kinases
Czasopismo naukowe
Tytuł:
YTHDC2 Retards Cell Proliferation and Triggers Apoptosis in Papillary Thyroid Cancer by Regulating CYLD-Mediated Inactivation of Akt Signaling.
Autorzy:
Zhou G; Department of Thyroid and Breast Surgery, Shandong Provincial Third Hospital, Shandong University, Jinan, 250031, China.
Wang S; Department of Radiotherapy, the 960Th Hospital of Chinese PLA, No. 25 Shifan Road, Jinan, 250031, China. .
Pokaż więcej
Źródło:
Applied biochemistry and biotechnology [Appl Biochem Biotechnol] 2024 Jan; Vol. 196 (1), pp. 588-603. Date of Electronic Publication: 2023 May 10.
Typ publikacji:
Journal Article
MeSH Terms:
Proto-Oncogene Proteins c-akt*/genetics
Thyroid Neoplasms*/genetics
Thyroid Neoplasms*/metabolism
Humans ; Thyroid Cancer, Papillary/genetics ; Thyroid Cancer, Papillary/metabolism ; Caspase 3/metabolism ; Cell Proliferation/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Apoptosis/genetics ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic ; Deubiquitinating Enzyme CYLD/genetics ; Deubiquitinating Enzyme CYLD/metabolism ; RNA Helicases
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies